OCTIOCOR LTD Filleted Accounts Cover
OCTIOCOR LTD
Company No. 13840221
Unaudited Accounts
31 March 2025
OCTIOCOR LTD Balance Sheet Registrar
at
31 March 2025
Company No.
13840221
2025
2024
£
£
Fixed assets
1,5722,165
Current assets
196,642377,241
Prepayments and accrued income
48,37142,097
Creditors: Amounts falling due within one year
(16,213)
(33,359)
Net current assets
228,800385,979
Total assets less current liabilities
230,372388,144
Creditors: Amounts falling due after more than one year
(59,800)
(59,800)
Accruals and deferred income
(4,000)
(3,291)
166,572325,053
Capital and reserves
166,572
325,053
NOTES TO THE ACCOUNTS
1
Basis of preparation
These accounts have been prepared in accordance with the micro-entity provisions of the small companies regime.
2
Employees
2025
2024
Number
Number
The average monthly number of employees (including directors) during the year was:
2
1
3
General information
OCTIOCOR LTD is a private company limited by shares and incorporated in England and Wales.
Its registered number is:
13840221
Its registered office is:
Allia Future Business Centre
The Guildhall
Market Square
Cambridge
CB2 3QJ
For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A) of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
The accounts were approved by the board of directors on 29 November 2025 and signed on its behalf by:
M.R. Bennett - Director
OCTIOCOR LTD1384022131 March 202501 April 2024false29 November 2025BTCSoftware AP Solution 2025 12.1.0312.1.03The principal activity of the company during the year under review was the research and experimental development of biotechnology. 138402212024-04-012025-03-31138402212025-03-31138402212024-03-3113840221core:WithinOneYear2025-03-3113840221core:WithinOneYear2024-03-3113840221core:AfterOneYear2025-03-3113840221core:AfterOneYear2024-03-31138402212023-04-012024-03-3113840221countries:UnitedKingdom2024-04-012025-03-3113840221bus:RegisteredOffice2024-04-012025-03-31138402212024-04-0113840221bus:Micro-entities2024-04-012025-03-3113840221bus:FullAccounts2024-04-012025-03-3113840221bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113840221bus:Director12024-04-012025-03-3113840221bus:PrivateLimitedCompanyLtd2024-04-012025-03-31iso4217:GBPxbrli:pure